Sutro Biopharma Inc (NAS:STRO)
$ 2.75 0.1 (3.77%) Market Cap: 226.76 Mil Enterprise Value: -144.87 Mil PE Ratio: 0 PB Ratio: 2.04 GF Score: 64/100

Sutro Biopharma Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 08:30PM GMT
Release Date Price: $5.15 (-0.77%)
Roger Song
Jefferies - Analyst

Next presenting company is Sutro Biopharma and CEO, Bill Newell. Welcome.

Bill Newell
Sutro Biopharma, Inc. - CEO

Thank you, Roger. It's a pleasure to be here.

Questions & Answers

Roger Song
Jefferies - Analyst

Awesome. Great. Good to see you every year. All right. So for those people who may already know Sutro or just new to the story, what's your updated elevator pitch?

Bill Newell
Sutro Biopharma, Inc. - CEO

Roger, I think that what people are coming to appreciate is that we have a really unique proprietary platform that is delivering next-generation cancer therapeutics in a way that no one else in the industry can. We use a cell-free protein biosynthesis technology to develop molecules that have a differentiated profile.

And now, with so many of our programs in the clinic -- we've put six programs using our technology into clinical development, people are coming to appreciate the value of the way we construct an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot